University Hospital, Lille
Lille, 59037, France
NCT Number: NCT01458756
Organ transplantation has a special place in the medical field. It symbolizes a medicine whose limits always seem to be repelled. Because transplantation is unusual, it places people in front of outstanding issues which he has to cope with his personality and history. Factors involved in the psychology of patient presenting with graft are past and present psychic functioning, object relations, experience of transplantation itself and quality of social environment.
Before or after graft defense mechanisms can be so intense that they can make the patient unable to overcome the graft. Yet as a pathological mechanism that denial was considered beneficial provided it is short.
The aim of this study is to evaluate on psychopathological influence of psychological defense mechanisms used by liver transplant patients on their somatic psychological and social outcome.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Lille, 59037, France
The objective is to measure the influence of variations of psychological defense mechanisms.
The investigators want to measure the influence of personal history of patients, causal disease pre-existing, conditions of graft's realization, structure of patient's social environment (family or institutional); and wish to identify which of those elements can be protective or vulnerability factors with a view to allow adequate support (especially for patients who had multiple poor prognostic factors)
The investigators will study pre-transplant psychological defense mechanisms of the subjects using the Bond Defense Style Questionnaire and structure of personality using the SCID II personality scale. They will evaluate post-transplant patient outcomes on clinical and social developments with DSQ 88 and General Health Questionnaire (GHQ 28) to six months, twelve months and five years after transplantation. Meanwhile, they will address each time you visit the data on consumption, misuse and alcohol dependence using the AUDIT questionnaire (Alcohol Use Disorders Identification Test).
The hypothesis is that the defense mechanisms, their variations and personality of the patients are both vulnerability factors as protective factors in different phases of the graft. Identification should allow to optimize care and improve overall health. Results of this research could make it possible to determine the factors used in liaison psychiatry in the long term to ensure an adequate medical and psychiatric support to transplant patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: baseline and 6 months and 1 year and 5 years
Change in psychological defense mechanisms measured by the Defense Style Questionnaire 88, prior and after liver transplantation
Time frame: baseline and 6 months and 1 year and 5 years
structure of personality using the SCID II personality scale
Time frame: 6 months and 1 year and 5 years
presence of psychopathological disorders evaluated by MINI six months, one year and five years after liver transplantation
Time frame: baseline and 6 months and 1 year and 5 years
consumption, misuse and alcohol dependence measured by AUDIT score
Time frame: baseline and 6 months and 1 year and 5 years
Change in mental health levl measured by the General Health Questionnaire GHQ 28, prior and after liver transplantation
Time frame: baseline and 6 months and 1 year and 5 years
change in professional, family , financial states
University Hospital, Lille
Other
Evaluation of Psychological Defense Mechanisms Used by Liver Transplant Patients on Their Somatic Psychological and Social Outcome. Research for Protective or Vulnerability Factors.
Acronym: GHEPA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03235414
Digestive System Diseases, Liver Diseases
Cincinnati, Ohio, United States
View Trial DetailsNCT05272319
Digestive System Diseases, Liver Diseases
Los Angeles, California, United States
View Trial DetailsNCT05935488
Digestive System Diseases, Fibrosis
Norwich, Norfolk, United Kingdom
View Trial DetailsNCT06336018
Digestive System Diseases, Liver Diseases
Orange, California, United States
View Trial Details